Implications of complement activation in the efficacy of the monoclonal antibody cetuximab against lung cancer cells

Tesis doctoral de Yi-fan Hsu Background: cetuximab, an antibody targeting the epidermal growth factor receptor (egfr), increases survival in patients […]

, , , , ,